FDA Meeting to Discuss Future COVID-19 Boosters

3/21/22 — The FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on April 6 to discuss considerations for future COVID-19 vaccine booster doses and the process for selecting specific strains of the SARS-CoV-2 virus for COVID-19 vaccines to address current and emerging variants. Read the FDA announcement.